HK1141526A1 - Metal chelates having a perfluorinated peg group, method for the production thereof, and use thereof - Google Patents
Metal chelates having a perfluorinated peg group, method for the production thereof, and use thereofInfo
- Publication number
- HK1141526A1 HK1141526A1 HK10107994.9A HK10107994A HK1141526A1 HK 1141526 A1 HK1141526 A1 HK 1141526A1 HK 10107994 A HK10107994 A HK 10107994A HK 1141526 A1 HK1141526 A1 HK 1141526A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- production
- metal chelates
- peg group
- perfluorinated peg
- perfluorinated
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
- C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/04—X-ray contrast preparations
- A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
- A61K49/085—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier conjugated systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
- A61K49/10—Organic compounds
- A61K49/12—Macromolecular compounds
- A61K49/126—Linear polymers, e.g. dextran, inulin, PEG
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/0474—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- Radiology & Medical Imaging (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmacology & Pharmacy (AREA)
- Optics & Photonics (AREA)
- Physics & Mathematics (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102006049821A DE102006049821A1 (de) | 2006-10-18 | 2006-10-18 | Metallchelate mit perfluoriertem PEG-Rest, Verfahren zu deren Herstellung, sowie deren Verwendung |
US85296306P | 2006-10-20 | 2006-10-20 | |
US89007107P | 2007-02-15 | 2007-02-15 | |
PCT/EP2007/007284 WO2008046463A1 (de) | 2006-10-18 | 2007-08-11 | Metallchelate mit perfluoriertem peg-rest, verfahren zu deren herstellung sowie deren verwendung |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1141526A1 true HK1141526A1 (en) | 2010-11-12 |
Family
ID=38670854
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK10107994.9A HK1141526A1 (en) | 2006-10-18 | 2010-08-20 | Metal chelates having a perfluorinated peg group, method for the production thereof, and use thereof |
Country Status (22)
Country | Link |
---|---|
US (1) | US8263040B2 (de) |
EP (1) | EP2089362A1 (de) |
JP (1) | JP5475454B2 (de) |
KR (1) | KR101451446B1 (de) |
CN (1) | CN101687803B (de) |
AU (1) | AU2007312691A1 (de) |
BR (1) | BRPI0717466A2 (de) |
CA (1) | CA2666910C (de) |
CO (1) | CO6170342A2 (de) |
CR (1) | CR10727A (de) |
CU (1) | CU23837B1 (de) |
DE (1) | DE102006049821A1 (de) |
GT (1) | GT200900087A (de) |
HK (1) | HK1141526A1 (de) |
IL (1) | IL198173A0 (de) |
MX (1) | MX2009004097A (de) |
MY (1) | MY148553A (de) |
NO (1) | NO20091912L (de) |
NZ (1) | NZ576249A (de) |
RU (1) | RU2470014C2 (de) |
SG (1) | SG177994A1 (de) |
WO (1) | WO2008046463A1 (de) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2178862A1 (de) * | 2007-08-13 | 2010-04-28 | GE Healthcare AS | Chelatbildner, paramagnetische chelate daraus und ihre verwendung als kontrastmittel in der magnetresonanzbildgebung (mri) |
WO2017189967A1 (en) * | 2016-04-29 | 2017-11-02 | University Of Houston System | Compositions, methods and kits for treating a contact lens |
JP7100704B2 (ja) * | 2018-05-16 | 2022-07-13 | グアンジョウ ユーアール マテリアルズ テクノロジー カンパニー,リミテッド | パーフルオロポリエーテル基含有シラン化合物、その製造方法、表面処理剤及び物品 |
KR102618166B1 (ko) * | 2019-03-29 | 2023-12-28 | 다이킨 고교 가부시키가이샤 | 플루오로폴리에테르기 함유 화합물 |
Family Cites Families (39)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4588279A (en) * | 1982-10-27 | 1986-05-13 | Konishiroku Photo Industry Co., Ltd. | Cleaning roller intermediate transfer member |
US4586511A (en) * | 1983-03-04 | 1986-05-06 | Children's Hospital Medical Center | Methods and compositions for detecting and imaging a gas in an animal by nuclear magnetic resonance |
US4639364A (en) * | 1984-11-14 | 1987-01-27 | Mallinckrodt, Inc. | Methods and compositions for enhancing magnetic resonance imaging |
EP0292306A3 (de) | 1987-05-20 | 1989-09-13 | Nippon Shokubai Co., Ltd. | Kondensate von Methylolaminotriazin und Verfahren zu deren Herstellung |
US4838274A (en) | 1987-09-18 | 1989-06-13 | Air Products And Chemicals, Inc. | Perfluoro-crown ethers in fluorine magnetic resonance imaging |
US5114703A (en) | 1989-05-30 | 1992-05-19 | Alliance Pharmaceutical Corp. | Percutaneous lymphography using particulate fluorocarbon emulsions |
DE4008179A1 (de) * | 1990-03-12 | 1991-09-19 | Schering Ag | Fluorbenzolsulfonamide |
US5250283A (en) | 1990-03-28 | 1993-10-05 | Molecular Biosystems, Inc. | Organic contrast agent analog and method of making same |
US5318770A (en) | 1991-10-25 | 1994-06-07 | Mallinckrodt Medical, Inc. | Trifluoromethyl analogs of X-ray contrast media for magnetic resonance imaging |
DE4203254C2 (de) | 1992-02-05 | 1996-05-02 | Max Planck Gesellschaft | Fluorhaltige Markierungsverbindung für NMR-Untersuchungen und deren Verwendung |
US5482650A (en) * | 1992-04-28 | 1996-01-09 | Minnesota Mining And Manufacturing Company | Liquid crystal compounds having perfluoroether terminal portions |
US5756688A (en) * | 1992-10-14 | 1998-05-26 | Sterling Winthrop Inc. | MR imaging compositions and methods |
US5362478A (en) * | 1993-03-26 | 1994-11-08 | Vivorx Pharmaceuticals, Inc. | Magnetic resonance imaging with fluorocarbons encapsulated in a cross-linked polymeric shell |
US5401493A (en) | 1993-03-26 | 1995-03-28 | Molecular Biosystems, Inc. | Perfluoro-1H,-1H-neopentyl containing contrast agents and method to use same |
DE4317588C2 (de) * | 1993-05-24 | 1998-04-16 | Schering Ag | Fluorhaltige makrocyclische Metallkomplexe, Verfahren zu ihrer Herstellung, sowie ihre Verwendung |
JPH0797340A (ja) | 1993-06-03 | 1995-04-11 | Terumo Corp | Mri造影剤組成物 |
US5502094A (en) * | 1994-05-20 | 1996-03-26 | Minnesota Mining And Manufacturing Company | Physiologically acceptable emulsions containing perfluorocarbon ether hydrides and methods for use |
US5702637A (en) * | 1995-04-19 | 1997-12-30 | Minnesota Mining And Manufacturing Company | Liquid crystal compounds having a chiral fluorinated terminal portion |
DE19603033A1 (de) * | 1996-01-19 | 1997-07-24 | Schering Ag | Perfluoralkylhaltige Metallkomplexe, Verfahren zu deren Herstellung und ihre Verwendung in der NMR-Diagnostik |
DE19729013A1 (de) * | 1997-07-03 | 1999-02-04 | Schering Ag | Oligomere, perfluoralkylhaltige Verbindungen, Verfahren zu deren Herstellung und ihre Verwendung in der NMR-Diagnostik |
DE19744003B4 (de) * | 1997-09-26 | 2004-07-08 | Schering Ag | Kontrastmittel für das Infarkt- und Nekroseimaging |
US6495118B1 (en) * | 1997-09-26 | 2002-12-17 | Schering Aktiengesellschaft | Lipophilic metal complexes for necrosis and infarction imaging |
DE19744004C1 (de) | 1997-09-26 | 1999-07-22 | Schering Ag | Lipophile Metall-Komplexe für Nekrose und Infarkt-Imaging |
HUP0101245A3 (en) | 1997-10-02 | 2003-10-28 | Epix Pharmaceuticals Inc Cambr | Contrast-enhanced diagnostic imaging method for monitoring interventional therapies |
DE19914101C1 (de) | 1999-03-22 | 2000-10-12 | Schering Ag | Perfluoralkylamide, ihre Herstellung und ihre Verwendung in der Diagnostik |
US6461587B1 (en) * | 1999-03-22 | 2002-10-08 | Schering Aktiengesellschaft | Perfluoroalkylamides, their production and their use in diagnosis |
DE19948651B4 (de) * | 1999-09-29 | 2006-10-05 | Schering Ag | Para- und diamagnetische perfluorhaltige Verbindungen enthaltende galenische Formulierungen, deren Herstellung und Verwendung |
US6939329B1 (en) * | 1999-10-08 | 2005-09-06 | Harvest Technologies Corporation | Apparatus for holding and operating one or more syringes |
DE10040858C2 (de) * | 2000-08-11 | 2003-12-18 | Schering Ag | Perfluoralkylhaltige Komplexe mit polaren Resten, Verfahren zu deren Herstellung und ihre Verwendung |
DE10040381C1 (de) * | 2000-08-11 | 2002-06-06 | Schering Ag | Perfluoralkylhaltige Komplexe mit Zuckerresten, Verfahren zu deren Herstellung und ihre Verwendung |
US6676928B2 (en) * | 2000-08-11 | 2004-01-13 | Schering Aktiengesellschaft | Perfluoroalkyl-containing complexes with polar radicals, process for their production and their use |
US6641797B2 (en) * | 2000-08-11 | 2003-11-04 | Schering Aktiengesellschaft | Perfluoroalkyl-containing complexes with sugar radicals, process for their production and their use |
DE10066210B4 (de) | 2000-08-11 | 2008-02-28 | Bayer Schering Pharma Ag | Verwendung von perfluoralkylhaltigen Metallkomplexen als Kontrastmittel im MR-Imaging zur Darstellung von Plaques |
RU2206605C1 (ru) * | 2002-03-18 | 2003-06-20 | Здоров Юрий Павлович | Противоизносная присадка к смазочным средам и топливу |
JP2005531647A (ja) * | 2002-04-11 | 2005-10-20 | カルボマー インク | 新規なイメージングプローブ |
US7344704B2 (en) * | 2002-07-10 | 2008-03-18 | Schering Ag | Use of perfluoroalkyl-containing metal complexes as contrast media in MR-imaging for visualization of intravascular thrombi |
JP2004101881A (ja) * | 2002-09-10 | 2004-04-02 | Konica Minolta Holdings Inc | ドライイメージング材料 |
US8147806B2 (en) * | 2004-01-16 | 2012-04-03 | Carnegie Mellon University | Cellular labeling for nuclear magnetic resonance techniques |
RU2296756C2 (ru) * | 2005-05-17 | 2007-04-10 | Федеральное унитарное государственное предприятие "Государственный научно-исследовательский институт биологического приборостроения" (ГосНИИ БП) | Комплексообразующие дибензосодержащие пятичленные циклические соединения, содержащие два симметричных бета-дикарбонильных заместителя с фторированными радикалами |
-
2006
- 2006-10-18 DE DE102006049821A patent/DE102006049821A1/de not_active Withdrawn
-
2007
- 2007-08-11 AU AU2007312691A patent/AU2007312691A1/en not_active Abandoned
- 2007-08-11 JP JP2009532687A patent/JP5475454B2/ja not_active Expired - Fee Related
- 2007-08-11 CA CA2666910A patent/CA2666910C/en not_active Expired - Fee Related
- 2007-08-11 NZ NZ576249A patent/NZ576249A/en not_active IP Right Cessation
- 2007-08-11 CN CN2007800468109A patent/CN101687803B/zh not_active Expired - Fee Related
- 2007-08-11 RU RU2009118486/04A patent/RU2470014C2/ru not_active IP Right Cessation
- 2007-08-11 SG SG2012003893A patent/SG177994A1/en unknown
- 2007-08-11 BR BRPI0717466-7A2A patent/BRPI0717466A2/pt not_active IP Right Cessation
- 2007-08-11 WO PCT/EP2007/007284 patent/WO2008046463A1/de active Application Filing
- 2007-08-11 MX MX2009004097A patent/MX2009004097A/es active IP Right Grant
- 2007-08-11 KR KR1020097009975A patent/KR101451446B1/ko not_active IP Right Cessation
- 2007-08-11 MY MYPI20091583A patent/MY148553A/en unknown
- 2007-08-11 EP EP07801728A patent/EP2089362A1/de not_active Withdrawn
- 2007-10-17 US US11/873,986 patent/US8263040B2/en not_active Expired - Fee Related
-
2009
- 2009-04-16 IL IL198173A patent/IL198173A0/en unknown
- 2009-04-17 GT GT200900087A patent/GT200900087A/es unknown
- 2009-04-17 CU CU2009000059A patent/CU23837B1/es not_active IP Right Cessation
- 2009-04-17 CR CR10727A patent/CR10727A/es not_active Application Discontinuation
- 2009-04-17 CO CO09039146A patent/CO6170342A2/es active IP Right Grant
- 2009-05-15 NO NO20091912A patent/NO20091912L/no not_active Application Discontinuation
-
2010
- 2010-08-20 HK HK10107994.9A patent/HK1141526A1/xx unknown
Also Published As
Publication number | Publication date |
---|---|
WO2008046463A1 (de) | 2008-04-24 |
SG177994A1 (en) | 2012-02-28 |
MY148553A (en) | 2013-04-30 |
KR20090082222A (ko) | 2009-07-29 |
IL198173A0 (en) | 2009-12-24 |
CO6170342A2 (es) | 2010-06-18 |
NZ576249A (en) | 2012-03-30 |
EP2089362A1 (de) | 2009-08-19 |
RU2009118486A (ru) | 2010-11-27 |
AU2007312691A1 (en) | 2008-04-24 |
KR101451446B1 (ko) | 2014-10-16 |
BRPI0717466A2 (pt) | 2014-04-15 |
MX2009004097A (es) | 2009-07-10 |
NO20091912L (no) | 2009-07-17 |
CN101687803B (zh) | 2012-05-30 |
DE102006049821A1 (de) | 2008-04-24 |
GT200900087A (es) | 2010-04-19 |
CA2666910A1 (en) | 2008-04-24 |
CA2666910C (en) | 2013-12-24 |
US8263040B2 (en) | 2012-09-11 |
US20080159954A1 (en) | 2008-07-03 |
RU2470014C2 (ru) | 2012-12-20 |
CN101687803A (zh) | 2010-03-31 |
CU20090059A7 (es) | 2011-03-21 |
JP2010506862A (ja) | 2010-03-04 |
CR10727A (es) | 2009-07-23 |
CU23837B1 (es) | 2012-10-15 |
JP5475454B2 (ja) | 2014-04-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EG25305A (en) | Method for the production of a strip made of steel. | |
IL204555A0 (en) | (carboxylalkylene-phenyl) phenyl-oxalamides, method for the production thereof, and use of same as a medicatment | |
ZA200908428B (en) | Method for the production of a component, and component | |
EP2103711A4 (de) | Hoch korrosionsbeständige elemente und herstellungsverfahren dafür | |
EP1951609A4 (de) | Verfahren zur herstellung eines mikroelektromechanischen bauteils und mikroelektromechanisches bauteil | |
IL185804A0 (en) | Aminocarbonyl-substituted 8-n-benzimidazoles, method for their production and their use as medicaments | |
EP2050834A4 (de) | Dr-stahlblech und herstellungsverfahren dafür | |
EP2055797A4 (de) | Eisenlegierung und herstellungsverfahren dafür | |
IL204556A0 (en) | (cyclopropyl-phenyl)-phenyl-oxalamides, method for the production thereof, and use of same as a medicament | |
EP1951611A4 (de) | Verfahren zur herstellung eines mikroelektromechanischen bauteils und mikroelektromechanisches bauteil | |
HK1204471A1 (en) | Benzyl amines, a process for their production and their use as anti- inflammatory agents | |
PL2106225T3 (pl) | Pościel aromaterapeutyczna i sposób jej wytwarzania | |
IL193560A0 (en) | Novel microorganism and method for producing dodecahydro-3a,6,6,9a- | |
BRPI0719706A2 (pt) | Processo para a preparação do 1,3-propanodiol. | |
PT2225314T (pt) | Silicones-autoadesivos, método de fabrico, complexos que os utilizam e aplicações | |
ZA200810659B (en) | A carried nano-catalyst and method for production thereof | |
EP2018947A4 (de) | Form für eine dichtung, verfahren zur herstellung der dichtung und dichtung | |
HK1141526A1 (en) | Metal chelates having a perfluorinated peg group, method for the production thereof, and use thereof | |
ZA200805382B (en) | Keratin-binding effector molecules, and method for the production thereof | |
MX285136B (es) | Metodo de produccion de polieteramina. | |
EP1928644A4 (de) | Klinge, bestandteile einer klinge und verfahren zur herstellung einer klinge und der bestandteile einer klinge | |
EP1939184A4 (de) | 1,3-diiodhydantoinverbindung und verfahren zu deren herstellung | |
EP2351496A4 (de) | Unterhose für männer und herstellungsverfahren dafür | |
EP1995335A4 (de) | Verfahren zur herstellung eines metallelements und strukturelement | |
EP2371819A4 (de) | Neue chinolinderivate, herstellungsverfahren und deren verwendung zur behandlung mikrobakterieller infektionen, und eine auf diesen derivaten basierende pharmazeutische zusammensetzung |